Intrathecal chemotherapy and bone marrow
TO THE EDITOR cellular spaces of the CNS. 7 Two plexuses of veins, external and internal, extend along the entire length of the vertebral The systemic effects of intrathecal chemotherapy have been column, form a series of moderately distinct rings around each vertebra, and anastomose freely with each other, receiving well described, including leukopenia 1,2 and tumor lysis syndrome.
3,4 The dosages of intrathecally injected drugs are tributaries from the vertebrae, ligaments and spinal cord. They are relatively devoid of valves. 8 The intervertebral veins drain rather low when compared with those used in a systemic manner. This finding implies that there may be possible mechblood from the spinal cord and from the internal and external vertebral plexuses. Whether they contain effective valves is anisms contributing to the striking systemic and bone marrow activity of these intrathecally administered chemotherapeutic uncertain, but experimental data strongly suggest that their blood flow can be reversed. 9 In addition, the internal vertebral agents. Here, we suggest a plausible explanation.
Methotrexate is not metabolized in the cerebrospinal fluid plexus has connections with the pelvic veins. This anatomical relationship between the medulla spinalis (CSF) and its intrathecal injection provides a slow-release reservoir of methotrexate into the bloodstream with prolonged and the bone marrow, particularly with vertebral and pelvic compartments might explain the sensitivity to intrathecal cytotoxic levels.
4,5 Likewise, cytidine deaminase which activates cytarabine is lacking in the CSF 6 leading to higher and chemotherapy leading to myelosuppression and tumor lysis syndrome in patients having bone marrow infiltration. Further more prolonged CSF levels of this drug. After achieving considerable concentrations in the CSF, intrathecal drugs may investigations including animal studies are necessary to fully elucidate the validity of this hypothesis. enter the systemic circulation by passive diffusion. Cytarabine and methotrexate are principally eliminated by the liver and I · Barışta Department of Medical Oncology, kidney, respectively. Therefore, these drugs should somehow avoid the hepatic metabolism and/or renal excretion in order I · Ç elik Institute of Oncology, I · H Güllü
Hacettepe University, to have dramatic systemic effects. The veins of the central nervous system (CNS) and medulla spinalis finally drain into the Ş Yalçın Ankara, Turkey superior and inferior venae cavae so that the first-pass hepatic metabolism is avoided, but intravenously administered drugs also follow this route, hence this explanation seems unlikely.
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